ZERBAXA

Google image searchProduct monograph

Active ingredients

ceftolozane (ceftolozane sulfate), 1 G/VIAL

tazobactam (tazobactam sodium), 0.5 G/VIAL

DIN: 02446901

Dosage form(s): POWDER FOR SOLUTION

Route(s) of administration: INTRAVENOUS

Description: SINGLE USE VIALS

Schedule: Prescription

Company: MERCK CANADA INC

Date: 12-JAN-2016

ATC:

• J01 — ANTIBACTERIALS FOR SYSTEMIC USE (ATC, ATC/DDD, )
• J01D — OTHER BETA-LACTAM ANTIBACTERIALS (ATC, ATC/DDD)
• J01DI — Other cephalosporins (ATC, ATC/DDD)
• J01DI54 — CEFTOLOZANE AND BETA-LACTAMASE INHIBITOR (ATC/DDD)

Reference brand drug: Zerbaxa

External Links for Zerbaxa

Search on Google

• Zerbaxa side effects
• Zerbaxa dosage
• ceftolozane side effects
• ceftolozane dosage
• tazobactam side effects
• tazobactam dosage

Merck Canada Inc

Go to Merck website to see drug product details. Sometimes you can find zerbaxa photos and/or monograph. If you are a healthcare professional, you may need to enter your license number.